RSV Diagnostics Market

Because mild RSV symptoms are similar to the common cold, testing usually isn't required to diagnose the infection. However, your doctor may suspect RSV based on your medical history, time of year and a physical exam. In this case, they may want to run lab tests to confirm the diagnosis. The most common is a mouth swab or a blood test to check white blood cell counts and look for viruses.

RSV Diagnostics Market contains market size and forecasts of RSV Diagnostics in Global, including the following market information:

• Global RSV Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global top five companies in 2021 (%)

The global RSV Diagnostics market was valued at 765 million in 2021 and is projected to reach US$ 1251.4 million by 2028, at a CAGR of 7.3% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Kits and Assays Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of RSV Diagnostics include bioM rieux, Abbott, Roche, BD, Thermo Fisher, Luminex, Danaher, Biocartis and Hologic. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the RSV Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global RSV Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global RSV Diagnostics Market Segment Percentages, by Type, 2021 (%)

• Kits and Assays
• Instruments
• Other

Global RSV Diagnostics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global RSV Diagnostics Market Segment Percentages, by Application, 2021 (%)

• Hospitals & Clinics
• Clinical Laboratories
• Homecare

Global RSV Diagnostics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global RSV Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies RSV Diagnostics revenues in global market, 2017-2022 (estimated), ($ millions)
• Key companies RSV Diagnostics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• bioM rieux
• Abbott
• Roche
• BD
• Thermo Fisher
• Luminex
• Danaher
• Biocartis
• Hologic